BEAM Alliance is proposing a new approach to foster better differentiation between antimicrobials: ‘A new vision for AMR innovation to support medical care’!

Key messages

• Antimicrobial resistance (AMR) is a global, multi-sectoral issue that affects all countries and, if unaddressed, would widely stress health systems
• To curb the AMR threat, the range of infection challenges and medical needs must be matched with a diversity of informed treatment approaches
• A diverse pipeline of innovative solutions is being developed by SMEs to meet this challenge
• New outcomes, and tools to quantify them, are now awaited to help differentiating existing and upcoming products and measure their performance

To do so, a categorization of the antimicrobial approaches based on the pathogenesis of infectious disease is proposed.

Full Memo available here